Together, these data indicate that simultaneous inhibition of autophagy and the FGFR1 pathway by CP@NP‐cRGD could sharply reverse AZD9291 resistance in NSCLC cell lines. Here, FGFR1 is linked to non-small cell lung carcinoma.